Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
This piece explains Why Stablecoin Liquidity Matters, linking market health to trading efficiency and user experience for investors.
24,049 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
A veteran financial writer dives into a framework that aims to outpace the S&P over generations. Learn how Davis Fund...
SoftBank Group stock tumbled about 20% over the past five trading days as questions surrounding OpenAI funding and th...
The FDA recently approved fruit-flavored e-cigarettes, prompting scrutiny from health advocates and investors. A new ...
JetBlue sparked attention by boosting its Q2 unit-revenue outlook, lifting airline sentiment and offering clues for t...
When work gets intense, money decisions get louder. This article breaks down how intensity at work affects your budge...
A Harvard scholar outlines how the data-center backlash is gaining steam as AI demand grows, energy costs rise, and l...
A broad pullback in the Magnificent Seven pushed the tech rally into a correction. Yet analysts say this may reflect ...
ServiceNow sprinted higher on Friday as AI and automation headlines fueled optimism. This piece breaks down the catal...
A storied dividend king trades at a discount as Wall Street shifts away. Here’s why patient investors are doubling do...
When a loved one appears on a jail roster, scam artists step in with urgent payment requests. Learn how to spot these...
Camtek reports Q1 2026 revenue of $121.66 million with a booming backlog worth over $260 million for 2026-27, undersc...